Zhejiang Jingxin Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZHEJIANG JINGXIN, and what generic and branded alternatives to ZHEJIANG JINGXIN drugs are available?
ZHEJIANG JINGXIN has three approved drugs.
Drugs and US Patents for Zhejiang Jingxin
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zhejiang Jingxin | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 091491-003 | Dec 14, 2010 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zhejiang Jingxin | COLESEVELAM HYDROCHLORIDE | colesevelam hydrochloride | TABLET;ORAL | 209946-001 | Jul 15, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zhejiang Jingxin | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 206513-003 | Mar 1, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.